S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
NYSE:IMPR

Imprivata (IMPR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$19.26
$19.26
50-Day Range
N/A
52-Week Range
$9.00
$20.32
Volume
N/A
Average Volume
258,396 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
IMPR stock logo

About Imprivata Stock (NYSE:IMPR)

Imprivata, Inc. (Imprivata) is a United States-based healthcare information technology security company. The Company enables healthcare organizations to access, communicate and transact patient information securely. The Company offers Imprivata OneSign, Imprivata Cortext, Imprivata Confirm ID and Imprivata PatientSecure. Imprivata OneSign provides single sign-on, authentication management and virtual desktop roaming, enabling No Click Access to clinical applications and patient information, anytime, anywhere and from any device. Imprivata Cortext enables clinicians to collaborate across care teams and organizations. Imprivata Confirm ID is an identity and two-factor authentication platform for remote access, electronic prescriptions for controlled substances (EPCS), medical device access and other clinical authentication workflows. Imprivata PatientSecure is a patient identification solution that uses palm vein recognition biometrics to identify patients at any point of entry to care.

IMPR Stock News Headlines

The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Aware, Inc. (AWRE) Q4 2023 Earnings Call Transcript
HIGHLAND CAPITAL PARTNERS VI LP's Net Worth
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Zscaler Reports First Quarter Fiscal 2024 Financial Results
Philipstown and Putnam Election Results
Election Guide
Zscaler (ZS) Announces New Zero-Trust Security Solution
See More Headlines
Receive IMPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Imprivata and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/16/2016
Today
4/17/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

IMPR Stock Analysis - Frequently Asked Questions

How were Imprivata's earnings last quarter?

Imprivata, Inc. (NYSE:IMPR) released its quarterly earnings data on Tuesday, February, 16th. The technology company reported ($0.09) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.10) by $0.01. The technology company had revenue of $34.20 million for the quarter, compared to the consensus estimate of $33.15 million. The business's revenue for the quarter was up 17.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.04) earnings per share.

What other stocks do shareholders of Imprivata own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Imprivata investors own include Teledyne FLIR (FLIR), Allegion (ALLE), Anixter International (AXE), Avigilon (AVO), Ascent Capital Group Inc Series A (ASCMA), ASSA ABLOY AB (publ) (ASAZY), Applied DNA Sciences (APDN), Alarm.com (ALRM), 23965 (AF.TO) (AF) and ADT (ADT).

This page (NYSE:IMPR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners